Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 13/20 | 1.00 |
| ▸ | DRD3 | P35462 | 4/20 | 1.00 |
| ▸ | HTR2C | P28335 | 3/20 | 1.00 |
| ▸ | ADRB1 | P08588 | 3/20 | 1.00 |
| ▸ | HTR1A | P08908 | 3/20 | 1.00 |
| ▸ | DRD2 | P14416 | 3/20 | 1.00 |
| ▸ | DRD4 | P21917 | 3/20 | 1.00 |
| ▸ | HTR2B | P41595 | 3/20 | 1.00 |
| ▸ | HTR6 | P50406 | 3/20 | 1.00 |
| ▸ | ADRB2 | P07550 | 2/20 | 1.00 |
| ▸ | HRH1 | P35367 | 2/20 | 1.00 |
| ▸ | DRD5 | P21918 | 1/20 | 1.00 |
| ▸ | HTR1D | P28221 | 1/20 | 1.00 |
| ▸ | HTR1E | P28566 | 1/20 | 1.00 |
| ▸ | HTR7 | P34969 | 1/20 | 1.00 |
| ▸ | HTR5A | P47898 | 1/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.72 |
| ▸ | MEN1 | O00255 | 3/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lysergide SCHEMBL30416462 | 1.00 | HTR2A (1.00) | HTR2ADRD3HTR2CADRB1HTR1A | |
| Lysergide SCHEMBL30949883 | 1.00 | HTR2A (1.00) | HTR2ADRD3HTR2CADRB1HTR1A | |
| Lysergide SCHEMBL29349465 | 1.00 | HTR2A (1.00) | HTR2ADRD3HTR2CADRB1HTR1A | |
| Lysergide SCHEMBL27221708 | 1.00 | HTR2A (1.00) | HTR2ADRD3HTR2CADRB1HTR1A | |
| Lysergide SCHEMBL23741954 | 1.00 | HTR2A (1.00) | HTR2ADRD3HTR2CADRB1HTR1A | |
| Lysergide SCHEMBL467940 | 1.00 | HTR2A (1.00) | HTR2ADRD3HTR2CADRB1HTR1A | |
| Lysergide SCHEMBL24449764 | 1.00 | HTR2A (1.00) | HTR2ADRD3HTR2CADRB1HTR1A | |
| Lysergide SCHEMBL12401704 | 1.00 | HTR2A (1.00) | HTR2ADRD3HTR2CADRB1HTR1A | |
| Lysergide SCHEMBL22774200 | 0.99 | HTR2A (0.98) | HTR2ADRD3HTR2CADRB1HTR1A | |
| Lysergide SCHEMBL28855252 | 0.99 | HTR2A (0.98) | HTR2ADRD3HTR2CADRB1HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7746 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122094837-A | Flexographic printing plate and mask for low contrast printing highlights | — | 2026-05-26 | — | — | CN | claimed |
| CN-122065867-A | UHF RFID integrated industrial washing label for folding label | 上海东鸿智能包装股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122018240-A | Plate-making exposure parameter setting method, device and medium for preprinted paperboard color sequence | 西安雄峰印刷包装有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-12611399-B2 | Movement disorders | Definium Therapeutics US, Inc. (US) | 2026-04-28 | — | — | US | claimed |
| EP-4351539-B1 | METHODS FOR THE PULSED DELIVERY OF BIOACTIVE AGENTS | UNIV MISSISSIPPI (US) | 2026-04-22 | — | — | EP | claimed |
| EP-4728531-A1 | BIOADAPTIVE THERAPEUTIC ENVIRONMENTS | Therapod LLC (US) | 2026-04-22 | — | — | EP | claimed |
| US-12605345-B2 | Transdermal drug delivery system | BioPhysics Pharma, Inc. (US) | 2026-04-21 | — | — | US | claimed |
| US-12594388-B2 | Device to deliver a predetermined amount of a substance to a natural orifice of the body | APTARGROUP, INC. (US) | 2026-04-07 | — | — | US | claimed |
| US-20260090584-A1 | SYSTEMS AND METHODS FOR ESTIMATING AEROSOLIZATION EMISSION | SCIENTIFIC HORIZONS CONSULTING LLC (US) | 2026-04-02 | — | — | US | claimed |
| US-20260090957-A1 | Process for making aqueous therapeutic particle having stable exterior water clustering with nanosized thickness | DRESDNER JR KARL P (US) | 2026-04-02 | — | — | US | claimed |
| CN-1067956-A | Make the method and apparatus of nitrogen for ultra-high purity | BOC GROUP INC (US) | 1993-01-13 | — | — | CN | claimed |
| WO-1992018868-A1 | CROSSTALK INHIBITORS AND THEIR USES | BIOSITE DIAGNOSTICS INCORPORATED (US) | 1992-10-29 | — | — | WO | claimed |
| WO-1992010200-A1 | FUNCTIONAL INTERACTIONS BETWEEN GLIAL S-100B AND CENTRAL NERVOUS SYSTEM SEROTONERGIC NEURONS | NEW YORK UNIVERSITY (US) | 1992-06-25 | — | — | WO | claimed |
| US-5102913-A | Treatment for cocaine use employing valproic acid | HALIKAS JAMES A (US) | 1992-04-07 | — | — | US | claimed |
| EP-0205068-B1 | LYSERGIC-ACID AMIDES, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM | ARZNEIMITTELWERK DRESDEN GmbH (DE) | 1992-01-02 | — | — | EP | claimed |
| US-5028611-A | Treatment for cocaine use | THE REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 1991-07-02 | — | — | US | claimed |
| EP-0095092-B1 | PROCESS FOR THE PREPARATION OF LYSERGIC ACID ESTERS | SCHERING AKTIENGESELLSCHAFT (DE) | 1986-12-30 | — | — | EP | claimed |
| US-4524208-A | Process for the preparation of lysergic acid esters | SCHERING AKTIENGESELLSCHAFT (DE) | 1985-06-18 | — | — | US | claimed |
| EP-0095092-A2 | Process for the preparation of lysergic acid esters | SCHERING AKTIENGESELLSCHAFT (DE) | 1983-11-30 | — | — | EP | claimed |
| US-4233030-A | Methods and apparatus for liquid chromatography | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1980-11-11 | — | — | US | claimed |